Scoparone is a major biological active substance derived from the traditional Chinese herbal medicine called Artemisia capillaris. It has been confirmed that scoparone has anti-inflammatory, anti-tumor, hepatoprotective and antioxidant effects. However, the binding interaction of scoparone with bovine serum albumin (BSA) still remains unknown. Therefore, the present study was conducted to clarify the binding interaction of scoparone with BSA under simulated physiological conditions (pH ¼ 
Introduction
Aer entering the blood circulation, drugs need to be stored and transported by plasma to reach the target tissue and exert pharmacological functions.
1 Serum albumin is the most abundant carrier protein in plasma. It can combine with many drugs to store and transport these drugs in plasma.
2 Therefore, the study of the mechanism on the interaction between drugs and serum albumin is helpful to understand the transportation and distribution of drugs in the body on the molecular level, and provide theoretical guidance and valuable information for designing more effective drugs, which has become a very focused research eld in chemicobiology, life sciences and medicine. 3 BSA is a heart-shaped protein consisting of 583 amino acid residues. It has three domains: domains I, II and III. Each domain has two subdomains, A and B. Two main drug binding sites (site I and site II) are respectively located in sub-domain IIA and sub-domain IIIA. 4, 5 Since the amino acid sequences of BSA and human serum albumin (HSA) are very similar and both have a high homology (approximately 76%), experimental studies oen use BSA instead of HSA to study the binding interaction of serum albumin with drugs. 6 Scoparone is a major biological active substance derived from the traditional Chinese herbal medicine called Artemisia capillaris. It has been reported that scoparone possesses anti-inammatory, anti-tumor, hepatoprotective and antioxidant effects, and is usually used to treat neonatal jaundice. 7, 8 Currently, many studies concerning the binding interaction of drugs with serum albumin have been carried out. However, the study about the interaction of serum albumin with scoparone has not been reported, which is very meaningful for understanding the mechanism of scoparone action and pharmacokinetics in the human body.
In this paper, uorescence spectroscopy, UV-vis absorption spectroscopy and circular dichroism spectroscopy were used to study the spectral characteristics about the binding interaction between scoparone and BSA in detail under simulated physiological conditions. Some important information about pharmacological mechanisms and pharmacokinetics of scoparone in vivo will be provided. dimethyl sulfoxide to prepare 100 mM storage solution. Ibuprofen (purity 99%) was obtained from Sinopharm Chemical Reagent Co., Ltd (Shanghai, China). Phenylbutazone (purity $ 98%) was obtained from Shanghai Aladdin biological technology Co., Ltd (Shanghai, China). BSA (purity > 96%) was bought from Gen-View Scientic INC (USA). BSA solution (1 Â 10 À4 mol L À1 ) was dissolved in 0.01 mol L À1 PBS. The stock solutions of phenylbutazone (6 Â 10 À3 mol L À1 ) and ibuprofen (6 Â 10 À3 mol L À1 ) were dissolved in ethanol. All storage solutions were preserved in dark at 4 C.
Fluorescence spectroscopy experiments
At three temperatures (290, 298 and 310 K), the uorescence spectroscopy experiments were performed by using the Hitachi F-7000 type Fluorescence Spectrophotometer (Hitachi HighTechnologies Co., Ltd., Tokyo, Japan) under 5/5 nm slit widths. The scanning wavelength range was 200-500 nm. The excitation wavelength was set at 280 nm. 9 In this research, considering the inner lter effect (IFE), so all uorescence intensities were corrected according to some references. [10] [11] [12] [13] .
Synchronous uorescence spectroscopy experiments
At 298 K, synchronous uorescence spectrum experiments were conducted. The wavelength intervals (Dl ¼ l em À l ex ) of 15 nm and 60 nm were respectively set. A 200-500 nm scanning wavelength range was set.
Circular dichroism (CD) spectroscopy experiments
CD spectroscopy experiments were carried out by using JASCO J-810 Spectrophotometer (Japan Spectroscopic Company, Tokyo, Japan) with a 1 mm quartz cell at 298 K. The scan rate was 100 nm min À1 and the scanning range was 190-250 nm with an interval of 1 nm.
UV-visible absorption spectrum experiments
At 298 K, UV-visible absorption spectrum experiments were conducted by utilizing UV-2700 spectrophotometer (Shimadzu Co., Kyoto, Japan). A 190-500 nm scanning wavelength range with an interval of 1 nm was set.
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Molecular docking
The 3D structure of scoparone was obtained from chemspider (http://www.chemspider.com). Then, it was converted into mol2 format by OpenBabel-2. 
Results and discussion
Effect of scoparone on uorescence spectra of BSA
The uorescence spectrum of proteins can reect the species, structure, microenvironment and distribution of the uores-cent chromophore groups in protein molecules. Protein molecules can emit strong endogenous uorescence due to amino acid residues, such as tryptophan, tyrosine and phenylalanine.
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When excited at 280 nm, protein uorescence is mainly caused by tryptophan, because the uorescence of tyrosine is practically totally quenched if it is ionized or near a carboxyl group, an amino group, or a tryptophan residue and phenylalanine has a very low quantum yield. 18, 19 The uorescence spectra about the interaction of scoparone with BSA at different temperatures were shown in Fig. 1 . When excited by exciting light with the wavelength of 280 nm, the maximum emission peak of BSA appeared at near 340 nm. When the concentration of BSA solution (1 Â 10 À5 mol L À1 ) was xed, the endogenous uo-rescence intensity of BSA decreased with the increase of scoparone concentrations. These results indicated that the interaction between scoparone and BSA occurred. 20 Sun et al. proved that isoalantolactone could interact with HSA to quench the endogenous uorescence of HSA, which was very similar to our experimental results.
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Fluorescence quenching can decrease the uorescence intensity by the excited molecules losing their energy, which generally induced by some molecular interactions, including excited-state reactions, collisional quenching, ground-state complex formation, molecular rearrangements and energy transfer. 22 The quenching effect of uorescence can usually be categorized into dynamic quenching and static quenching according to different quenching mechanisms. Static quenching can form a new complex between quenchers and uo-rophores, and the quenching constant decreases with . Curve g represented the fluorescence emission spectrum of 1 Â 10
increasing temperature. In contrast, for dynamic quenching, the quenching constant increases by increasing the collisional encounters that can be increased with increasing temperature. 23, 24 In the dynamic quenching process, the interaction between the uorophores and quenchers can be described by the Stern-Volmer equation:
where F and F 0 represent the uorescence intensities of BSA with or without the quencher (scoparone) respectively, [Q] means the concentration of scoparone, K q is the uorescence quenching rate constant of protein, K sv is the quenching constant, s 0 represents the mean uorescence lifetime of protein without quencher (s 0 is equal to 10 À8 s).
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A good linear relationship was found in Stern-Volmer plots at three different temperatures in Fig. 2A . The quenching constant of the intrinsic uorescence of BSA quenched by scoparone was decreased with the increasing temperatures. Moreover, the quenching rate constants (K q ) of BSA uores-cence were much greater than 2.0 Â 10 10 L mol À1 s À1 as shown in Table 1 . Based on these results, it could be seen that the uorescence quenching effect of scoparone to BSA was due to the static quenching caused by scoparone binding to BSA.
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For static quenching, the relationship between uorescence intensity and quencher concentration are according with Line weaver-Burk double logarithmic equation:
where [Q], F and F 0 are identical with eqn (1), n denotes the number of binding sites and K b means the binding constant.
at three temperatures were plotted as shown in Fig. 2B . From the slope and intercept of the plot, the binding constants (K b ) and number of binding sites (n) between BSA and scoparone could be obtained. As presented in Table 2 , the values of n were approximately equal to 1. In addition, the values of K b were in the magnitude of 10 5 mol L À1 , which meant that scoparone had a high affinity binding on BSA. 29 It is generally accepted that strong binding could decrease the concentration of free drug in plasma. However, weak binding could lead to a short life time or poor distribution. Due to scoparone having a strong affinity binding on BSA. It could be inferred that scoparone was slowly released in bloodstream and played a lasting pharmaceutical effect in vivo.
2
The binding forces between drug molecules and proteins mainly include hydrophobic interaction, van der Waals force, electrostatic force, and hydrogen bonding.
30 Ross et al. found some binding rules of small molecules and biomacromolecules, mainly including: when DH < 0 and DS < 0, the hydrogen bond and van der Waals force are the main forces. When DH z 0 and DS > 0, the electrostatic force dominates the interaction. When DH > 0 and DS > 0, the hydrophobic force plays the major role in interaction. 31 When the temperature does not change much, the enthalpy change (DH) of the reaction can be seen as a constant. According to the relative magnitudes of the thermodynamic parameters of enthalpy change (DH) and entropy change (DS) before and aer the reaction, the types of the main interaction forces between drug molecules and proteins can be acquired.
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The relationship of thermodynamic parameters is as follows:
where R represents the gas constant, T represents the experimental temperature and K b means the binding constant. The values of DH and DS can be obtained via the slope and intercept of curve of ln K b versus 1/T as shown in Fig. 3A . The values of DG can be obtained with eqn (4) . The values of DG, DH and DS were calculated as presented in Table 2 . The negative value of DG and positive values of DH and DS revealed that the interaction of scoparone with BSA was a spontaneous reaction mainly driven by hydrophobic interaction. Binding distance between scoparone and BSA Förster's theory of dipole-dipole non-radiative energy transfer states that when the energy donor is close enough with energy receptor and the distance is within 7 nm, the excited energy donor molecules will undergo non-radiative energy transfer with neighboring energy receptor molecules. 9 The energy transfer efficiency (E) and binding distance (r) between energy donor molecules (BSA) and energy receptor molecules (scoparone) can be determined. The value of E can be obtained by eqn (5):
where F and F 0 are identical with eqn (1), R 0 denotes the critical distance when E is 50%. The value of R 0 can be calculated with eqn (6):
where F represents the uorescence quantum yield of BSA, F is equal to 0.118, k 2 denotes the spatial orientation factor of the dipole, k 2 is equal to 2/3, N represents the average refractive index of the medium, N is equal to 1.336, and J(l) represents the spectral overlap integral between the absorption spectrum of scoparone and the emission spectrum of BSA. It can be computed with eqn (7):
where 3(l) and F(l) denote the molar extinction coefficient of scoparone and uorescence intensity of BSA at wavelength l, respectively. As shown in Fig. 3B , the uorescence emission spectrum of BSA partially overlapped with the UV-vis absorption spectrum of scoparone. The value of J(l) was 7.32 Â 10 À14 cm 3 L À1 mol À1 . Furthermore, the values of E, R 0 and r respectively were 11%, 3.42 nm and 4.81 nm. These experimental results revealed that the energy transfer from BSA to scoparone arose with a high possibility due to 0.5R 0 < r < 1.5R 0 and r < 7 nm.
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Synchronous uorescence spectra
In the synchronous uorescence spectrum analysis, Dl ¼ 15 nm shows the uorescence spectrum characteristic of tyrosine residues, and Dl ¼ 60 nm shows the uorescence spectrum characteristic of tryptophan residues. 35 The maximum emission wavelength of tyrosine and tryptophan residues in proteins is related to the polarity of the microenvironment in which these two residues are located. Therefore, the changes in the conformation of the proteins can be determined by observing the change of the maximum emission wavelength. 36 The BSA-scoparone system's synchronous uorescence spectrum can be obtained by xing the BSA concentration and increasing the scoparone concentrations gradually. As shown in Fig. 4 , the uorescence intensity of tryptophan and tyrosine residues in BSA was signicantly reduced with the increasing concentrations of scoparone. However, the pitch of quenching of Trp residues was more obvious than Tyr residues, which indicated that the binding site of scoparone on BSA was mainly focused on Trp nearby. 19 Furthermore, the maximum l em of Tyr residues almost did not change and a slight blue shi (2 nm) was found in the maximum l em of Trp residues. These results conrmed that there was almost no change in the microenvironment around Tyr residues but had slight change in the microenvironment around Trp residues, which meant that BSA conformation was altered slightly. Lou et al. conducted a study of the interaction between fungicide boscalid and BSA by synchronous uorescence spectra, proving that fungicide boscalid almost did Table 2 The thermodynamic parameters and binding constants of BSA quenched by scoparone at three temperatures . not change in the microenvironment around Tyr residues but made slight change in the microenvironment around Trp residues, which made our research results more convincing.
Circular dichroism spectroscopy
To further examine the changes in the conformation of BSA induced by scoparone, circular dichroism spectroscopy was used to study the interaction between scoparone and BSA. As shown in Fig. 5A , the circular dichroism spectra of BSA showed two negative peaks at near 208 nm and 222 nm, which were the characteristic peaks of the a-helix structure in BSA. The a-helix content was calculated by the following two formulas:
a-Helixð%Þ ¼ ÀMRE 208 À 4000 33000 À 4000 Â 100
where MRE is the residue ellipticity, C p represents the molar concentration of BSA, l denotes the path length and n means the number of amino acid residues (n ¼ 583, for BSA). 4000 represents the MRE value of the b-form and random coil conformation cross at 208 nm. 33 000 represent the MRE value of pure ahelix at 208 nm. MRE 208 denotes the observed MRE value at 208 nm. When the concentration of scoparone was gradually increased, the intensity of negative peaks of BSA at 208 and 222 nm in the circular dichroism spectra reduced, but the peak shape remained basically unchanged. In addition, by eqn (8) and (9), the calculated content of a-helix structure in BSA decreased from 45.26% to 42.14%. These results proved that the conformation of BSA was slightly changed by interaction with scoparone, which was consistent with the results of synchronous uorescence spectroscopy. Raza et al. conducted a study of the interaction between amphotericin B and BSA by circular dichroism spectra. The results revealed that with the increase of amphotericin B concentrations, the a-helix content of BSA decreased from 45.22% to 41.75%, which also showed that the conformation of BSA was slightly changed.
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UV-vis absorption spectra UV-vis absorption spectroscopy can usually be applied to research the protein conformational changes and complex formation between proteins and drugs. 28 As shown in Fig. 5B , there was a absorption peak at near 280 nm, because of the p / p* transition of some aromatic amino acids of BSA, including Phe, Tyr and Trp. 25 The absorption intensity of peak at about 280 nm increased with the increase of scoparone concentrations, revealing that a new complex of scoparone-BSA was formed. In addition, the changes of absorption spectrum of BSA 
This journal is © The Therefore, based on these molecular docking information and the results of thermodynamic parameters, it could be speculated that hydrophobic interaction was the main forces for scoparone binding to BSA.
Conclusions
In the present work, the interaction between scoparone and BSA under simulated physiological conditions was studied by uo-rescence spectroscopy, circular dichroism spectroscopy, UV-vis absorption spectroscopy and molecular simulation techniques. The results of uorescence spectroscopy indicated that scoparone quenched the endogenous uorescence of BSA and the quenching mechanism was static quenching. The binding between scoparone and BSA was a spontaneous reaction mainly driven by hydrophobic interaction. The results of molecular docking and the site marker experiment revealed that scoparone was more likely to be located in site I of BSA. The results of synchronous uorescence and circular dichroism spectroscopy conrmed that scoparone induced the conformational changes of BSA slightly. This study would be very useful for us to explain the pharmacokinetics of scoparone and the pharmacological mechanism. The efficacy and metabolism of scoparone in the human body will be further studied in future studies.
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